EverHint – Momentum Swing — Explosive Volume Breakout for Apr 30, 2026 – 15 Signals – Healthcare Leads (6)

What This Signal Is (Quick)

Explosive Volume Breakout is a momentum swing trading strategy focused on Breakouts with 2.5x+ volume surge - institutional buying pressure.

Signal Type: Breakout (momentum continuation)

What Makes This Signal:

• Stock showing strong momentum near or at highs
• Increased volume confirms institutional interest
• Breaking out or consolidating near resistance
• Breakouts with 2.5x+ volume surge - institutional buying pressure

Ideal For: Traders seeking breakouts with exceptional volume confirmation

Key Criteria:

• Strong RSI momentum (configurable thresholds)

• Volume surge above average

• Price momentum confirmation

• Minimum ADV: $25M+ (varies by variant)

• Earnings buffer: 7 days pre/post earnings

• Variant-specific filters applied

Holding Period: 1-4 weeks
Risk Level: Medium-High

How We Ranked Today

Ranked by composite momentum score (higher = stronger momentum)

📊 Momentum Swing — Explosive Volume Breakout Signals (Top 10 of 15 total)

Ranked by score:

Field Notes

Sector concentration: Healthcare (6), Industrials (4), Communication Services (2)

Insider selling: AXSM (Axsome Therapeutics, Inc., $-7.4M), GOOGL (Alphabet Inc., $-1.2M), GKOS (Glaukos Corporation, $-427K)

Near-term earnings: AXSM (Axsome Therapeutics, Inc.) report within 7 days. Higher volatility risk.

Data coverage: 33.3% insider, 13.3% congressional (1 recent/30d, 1 older/1y), 13.3% earnings, 100.0% analyst, 33.3% news

Peer Analysis

Understanding how these stocks relate to their industry peers:

GOOG (Alphabet Inc.): Leads 10 peers: MSFT ($407.78, -3.9%), META ($611.91, -8.6%), AAPL ($271.35, +0.4%), TSM ($396.06, +0.6%), NVDA ($199.57, -4.6%)

GTX (Garrett Motion Inc.): Leads 9 peers: VC ($111.71, +3.2%), RUSHA ($74.03, +2.9%), DORM ($112.51, +2.2%), HOG ($23.89, +1.1%), CARG ($36.46, -0.6%) | Peer of: ANF ($85.35, +1.5%), CARG ($36.46, -0.6%), DAN ($36.45, +1.8%) and 12 more

PWR (Quanta Services, Inc.): Leads 10 peers: VRT ($328.49, +7.3%), CSX ($45.43, +1.7%), JCI ($146.03, +3.3%), TDG ($1159.98, +1.5%), CP ($86.96, +3.2%) | Peer of: AXON ($401.76, +0.3%), CP ($86.96, +3.2%), CSX ($45.43, +1.7%) and 9 more

LFST (LifeStance Health Group, Inc.): Leads 9 peers: ACHC ($25.89, -8.4%), NHC ($173.29, -1.0%), AVAH ($6.54, -0.1%), MD ($22.51, +0.9%), ARDT ($9.76, +1.4%) | Peer of: ACHC ($25.89, -8.4%), AORT ($35.83, +3.4%), ARDT ($9.76, +1.4%) and 6 more

MTRN (Materion Corporation): Leads 9 peers: TMC ($5.24, +6.5%), BCC ($79.27, +0.3%), OLN ($28.48, +4.0%), SKE ($29.20, +0.6%), CSTM ($31.28, -3.0%) | Peer of: BCC ($79.27, +0.3%), CSTM ($31.28, -3.0%), EXK ($9.23, +3.7%) and 2 more

AXSM (Axsome Therapeutics, Inc.): Leads 8 peers: NUVL ($100.28, +1.2%), ABVX ($117.38, +10.5%), CYTK ($63.97, +7.4%), RYTM ($81.36, -0.9%), ARWR ($73.48, +4.2%) | Peer of: ABVX ($117.38, +10.5%), ARWR ($73.48, +4.2%), CORT ($46.52, -0.1%) and 5 more

IRM (Iron Mountain Incorporated): Leads 10 peers: EXR ($143.33, +2.0%), VICI ($29.22, +2.2%), VTR ($87.86, +0.6%), CSGP ($34.61, +1.4%), CCI ($88.78, +3.4%) | Peer of: CCI ($88.78, +3.4%), EXR ($143.33, +2.0%), MPT ($4.94, -3.7%) and 2 more

MYRG (MYR Group Inc.): Leads 9 peers: AGX ($669.98, +6.3%), TPC ($92.92, +8.0%), GVA ($137.07, +11.8%), BRC ($81.82, -0.2%), HAYW ($15.01, +0.7%) | Peer of: AGX ($669.98, +6.3%), BRC ($81.82, -0.2%), CAAP ($24.95, +2.2%) and 15 more

INDV (Indivior Pharmaceuticals Inc): Leads 10 peers: LNTH ($84.62, +4.2%), SUPN ($48.00, -1.1%), ACAD ($22.45, +1.1%), AMRX ($12.87, +0.6%), HNGE ($44.60, +1.4%) | Peer of: AMRX ($12.87, +0.6%), HNGE ($44.60, +1.4%), LNTH ($84.62, +4.2%) and 3 more

GOOGL (Alphabet Inc.): Leads 9 peers: MSFT ($407.78, -3.9%), META ($611.91, -8.6%), AAPL ($271.35, +0.4%), TSM ($396.06, +0.6%), NVDA ($199.57, -4.6%) | Peer of: AAPL ($271.35, +0.4%), META ($611.91, -8.6%), MSFT ($407.78, -3.9%) and 1 more

Congressional Activity

GOOGL (Alphabet Inc.) 🟢 Bullish (30d)

• 1 purchase by 1 member
• Pattern: Bipartisan agreement
• Top seller: Sen. Shelley Moore Capito (WV) - 1 transaction ($1,001 - $15,000)
• Top buyer: Hou. Cleo Fields (LA) - 3 transactions ($66,003 - $165,000)

GOOG (Alphabet Inc.) 🟢 Bullish (1y)

• 1 purchase by 1 member
• Top buyer: Sen. John Fetterman (PA) - 1 transaction ($1,001 - $15,000)

Recent Headlines

AXSM (Axsome Therapeutics, Inc.)

• US FDA approves Axsome's drug for Alzheimer's-related agitation (source)
• Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer's Disease (source)
• Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates (source)
• Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for (source)

MTRN (Materion Corporation)

• Materion (MTRN) Q1 Earnings and Revenues Top Estimates (source)
• Materion Corporation Reports Strong First Quarter 2026 Financial Results and Improves Full-Year Outlook (source)

MYRG (MYR Group Inc.)

• MYR Group Inc. to Attend KeyBanc Industrials & Basic Materials Conference in May (source)
• MYR Group Inc. (MYRG) Q1 2026 Earnings Call Transcript (source)
• MYR Group (MYRG) Q1 Earnings and Revenues Top Estimates (source)
• MYR Group Inc. Announces First-Quarter 2026 Results (source)

PWR (Quanta Services, Inc.)

• Quanta Services, Inc. (PWR) Q1 2026 Earnings Call Transcript (source)
• PWR Q1 Earnings Top Estimates on Strong Execution, 2026 View Raised (source)
• Here's What Key Metrics Tell Us About Quanta Services (PWR) Q1 Earnings (source)
• Allspring Growth Fund Q1 2026 Contributors And Detractors (source)
• Quanta Services (PWR) Tops Q1 Earnings and Revenue Estimates (source)
• Is Quanta Services (PWR) Overvalued After Q1 2026 Beat? GAAP EPS $1.45 vs $1.07 Est; Revenue $7.87B vs $6.998B Est -- GF Score 91/100, GF Value Says 73.4% Overvalued (source)
• Quanta Services Reports First Quarter 2026 Results (source)
• Comerica Bank Lowers Stock Position in Quanta Services, Inc. $PWR (source)
• Sterling vs. Quanta: Which Infrastructure Stock Wins Today? (source)
• What's in Store For These 4 Construction Stocks This Earnings Season? (source)
• Quanta to Report Q1 Earnings: Here's What Investors Must Know (source)

Market Context

Broad market indices advanced today, with the Dow Jones leading gains at +1.62%, followed by the S&P 500 at +1.08% and Nasdaq at +0.95%. This uniform upward trend signals strong risk appetite among investors, creating a favorable environment for momentum swing strategies reliant on explosive volume breakouts. The decisive moves across major benchmarks suggest sustained buying pressure, which can amplify breakout signals by providing the directional momentum needed for high-conviction entries.

The VIX's sharp decline of -9.99% to 16.93 reflects contracting volatility, reducing the likelihood of erratic intraday swings that often whipsaw momentum trades. Lower volatility supports cleaner breakout patterns, as it minimizes false signals and allows volume surges to propel prices more predictably in the prevailing uptrend. However, traders should remain vigilant for any VIX rebound, which could introduce choppiness and erode edge in swing positions.

With healthcare emerging as the top sector for signals amid broad market strength, sector rotation appears tilted toward resilient areas even in a risk-on climate. This dynamic bolsters the strategy's effectiveness, as healthcare's leadership could channel rotational flows into breakout opportunities, enhancing total signal conviction across the 15 setups.

Vlad's Take (EverHint)

Today's signals: Strong sector concentration in Healthcare (6 signals) suggests sector-specific rotation. 5 signals showing insider selling warrant caution. 2 signals with congressional buying (90-day) shows lawmaker confidence.

Sharing Call-to-Action

📢 If this analysis helped you, feel free to like, share, or subscribe — it helps the channel grow steadily.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/